EYPT

#1972
EyePoint, Inc. Common Stock
17.5600
+1.44%
Sector:
Base:
Profit Currency:
Daily Range
17.5600
17.5600
Year Range
9.6500
19.0100
Daily Change
+1.44%
Monthly Change
+11.10%
6 month change
+46.33%
Year Change
+46.33%
Previous Close
17.3100
Open
17.5600
Bid
Ask
Low
17.5600
High
17.5600
Volume
120
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 1.2284 B
  • Employee 144
  • Founded 1987
  • CEO N/A
  • Website www.eyepoint.bio
  • Headquarter Delaware, United States
  • FIGI BBG000F90JX5
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.75
Price to sales ratio
0.07
Dividends per share
—
Dividend yield %
—

EyePoint Inc

EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery. pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner. In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.

News